Impact of Lenalidomide in Management of FL and MZL

obr has 860 videos Subscribe Here

Description: Andre Goy, MD, Chairman and Director of the John Theurer Cancer Center (JTCC) at Hackensack University Medical Center and Chief of the Division of Lymphomas discusses how the approval of lenalidomide will impact how follicular lymphoma (FL) and marginal zone lymphoma (MZL) is managed.
Shared By : obr
Posted on : 06/27/19
Added : 24 days ago
Category : Lymphoma